| G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure. | |
| | |
MedLine Citation:
|
PMID: 18635825 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Myocardial G protein-coupled receptor kinase (GRK)2 is a critical regulator of cardiac beta-adrenergic receptor (betaAR) signaling and cardiac function. Its upregulation in heart failure may further depress cardiac function and contribute to mortality in this syndrome. Preventing GRK2 translocation to activated betaAR with a GRK2-derived peptide that binds G(beta)gamma (betaARKct) has benefited some models of heart failure, but the precise mechanism is uncertain, because GRK2 is still present and betaARKct has other potential effects. We generated mice in which cardiac myocyte GRK2 expression was normal during embryonic development but was ablated after birth (alphaMHC-Cre x GRK2 fl/fl) or only after administration of tamoxifen (alphaMHC-MerCreMer x GRK2 fl/fl) and examined the consequences of GRK2 ablation before and after surgical coronary artery ligation on cardiac adaptation after myocardial infarction. Absence of GRK2 before coronary artery ligation prevented maladaptive postinfarction remodeling and preserved betaAR responsiveness. Strikingly, GRK2 ablation initiated 10 days after infarction increased survival, enhanced cardiac contractile performance, and halted ventricular remodeling. These results demonstrate a specific causal role for GRK2 in postinfarction cardiac remodeling and heart failure and support therapeutic approaches of targeting GRK2 or restoring betaAR signaling by other means to improve outcomes in heart failure. |
| | |
Authors:
|
Philip W Raake; Leif E Vinge; Erhe Gao; Matthieu Boucher; Giuseppe Rengo; Xiongwen Chen; Brent R DeGeorge; Scot Matkovich; Steven R Houser; Patrick Most; Andrea D Eckhart; Gerald W Dorn; Walter J Koch |
Related Documents
:
|
2407395 - Catheter ablation using radiofrequency energy. 9134275 - Cannulation of the coronary sinus via the femoral vein--a new technique. 10415225 - Emergent right coronary artery thrombectomy with a jet aspiration thrombectomy catheter. 17652905 - Rescuing an entrapped guidewire using a tornus catheter. 7613425 - Volume and outcome in coronary artery bypass graft surgery: true association or artefact? 20107905 - Body size adjustments for left ventricular mass by cardiovascular magnetic resonance an... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2008-07-17 |
Journal Detail:
|
Title: Circulation research Volume: 103 ISSN: 1524-4571 ISO Abbreviation: Circ. Res. Publication Date: 2008 Aug |
Date Detail:
|
Created Date: 2008-08-15 Completed Date: 2008-09-05 Revised Date: 2012-06-07 |
Medline Journal Info:
|
Nlm Unique ID: 0047103 Medline TA: Circ Res Country: United States |
Other Details:
|
Languages: eng Pagination: 413-22 Citation Subset: IM |
Affiliation:
|
Center for Translational Medicine, Department of Medicine, Thomas Jefferson University, 1025 Walnut St, Philadelphia, PA 19107, USA. Philip.Raake@jefferson.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Cells, Cultured Disease Models, Animal Estrogen Antagonists / pharmacology G-Protein-Coupled Receptor Kinase 2 / genetics, metabolism* Gene Expression Regulation Heart Failure / metabolism*, pathology, prevention & control Ligation Mice Mice, Knockout Mice, Transgenic Myocardial Infarction / complications, metabolism*, pathology Myocytes, Cardiac / drug effects, metabolism*, pathology Receptors, Adrenergic, beta / metabolism Tamoxifen / pharmacology |
| Grant Support | |
ID/Acronym/Agency:
|
P01 HL075443/HL/NHLBI NIH HHS; P01 HL075443-050002/HL/NHLBI NIH HHS; R01 HL056205-08/HL/NHLBI NIH HHS; R01 HL061690-09/HL/NHLBI NIH HHS; R01 HL061690-10/HL/NHLBI NIH HHS; R01 HL061690-11/HL/NHLBI NIH HHS; R01 HL087871-06/HL/NHLBI NIH HHS; R01 HL088243-01/HL/NHLBI NIH HHS; R01 HL088243-02/HL/NHLBI NIH HHS; R01 HL56205/HL/NHLBI NIH HHS; R01 HL61690/HL/NHLBI NIH HHS; R01 HL87871/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Estrogen Antagonists; 0/Receptors, Adrenergic, beta; 10540-29-1/Tamoxifen; EC 2.7.11.15/Adrbk1 protein, mouse; EC 2.7.11.15/G-Protein-Coupled Receptor Kinase 2 |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Burst emergence of intracellular Ca2+ waves evokes arrhythmogenic oscillatory depolarization via the...
Next Document: Sleep duration and risk of ischemic stroke in postmenopausal women.